Nalaganje...
How I treat a refractory myeloma patient who is not eligible for a clinical trial
Myeloma patients not eligible for clinical trials have many treatment options. Choosing the next best therapy starts with careful assessment of the biology and dynamics of the disease at relapse, as well as the condition and situation of the patient. Fit patients should be considered for triplet reg...
Shranjeno v:
| izdano v: | Hematology Am Soc Hematol Educ Program |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Society of Hematology
2019
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6913488/ https://ncbi.nlm.nih.gov/pubmed/31808850 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/hematology.2019000016 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|